Altogether, PNPLA3 p.I148M and TM6SF2 p.E167K variants may promote steatosis and steatohepatitis which may indirectly predispose to progression of liver scarring (fibrosis and cirrhosis). This evidence concerns the gene PNPLA3 and Cirrhosis.